Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects
https://doi.org/10.21518/2079-701X-2019-6-14-19
Abstract
The article presents overview and statistical data on heart failure and cardiovascular diseases in Russia, world research data on various forms of heart failure in accordance with the modern classification, their clinical, anamnestic and prognostic differences, different approaches to the treatment of heart failure , discussion the prospects of this direction in cardiology, including the relevance of medical technology assessment.
About the Authors
E. F. Pavlysh
The Federal State Budgetary Institute «The Nikiforov Russian Center of Emergency and Radiation Medicine» The Ministry of Russian Federation for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters
Russian Federation
Russian Federation
Pavlysh Elena Fyodorovna – Cand. of Sci. (Med.), Head of the Laboratory of Echocardiography and Functional Visualization of the Cardiovascular System at the Department of Functional Diagnostics, Associate Professor of the Department of Therapy and Integrative Medicine at the Institute of Additional Professional Education of the Federal State Budget Institution «A.M. Nikiforov AllRussian Center of Emergency and Radiation Medicine» Ministry of Emergency Situations of Russia
Saint-Petersburg
V. N. Khirmanov
The Federal State Budgetary Institute «The Nikiforov Russian Center of Emergency and Radiation Medicine» The Ministry of Russian Federation for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters
Russian Federation
Russian Federation
Khirmanov Vladimir Nikolaevich – Dr. of Sci. (Med), Professor, Head of the Cardiovascular Pathology Department of the Federal State Budgetary Institution «A.M. Nikiforov AllRussian Center of Emergency and Radiation Medicine» Ministry of Emergency Situations of Russia
Saint-Petersburg
A. V. Pavlysh
Federal State Budgetary Educational Institution of Higher Education «North-Western State Medical University named after I.I. Mechnikov» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Pavlysh Andrey Vladislavovich – Dr. of Sci. (Med), Head of the Pharmacology and Pharmacy Department
191015, Saint-Petersburg, 41 Kirochnaya St.
References
1. Fomin I.V. Chronic Heart Failure in the Russian Federation: What We Know Today and What We Should Do. Russian Cardiology Journal [Rossijskij kardiologicheskij zhurnal]. 2016;8(136):7–13. (In Russ.)
2. Fomin I.V., Belenkov Yu.N., Mareev V.Yu., et al. The prevalence of chronic heart failure in the European part of the Russian Federation (part 1) – EHPOHA-HSN. Serdechnaya nedostatochnost. 2006;7,1(35):4-7. (In Russ.)
3. Fomin I.V., Belenkov Yu.N., Mareev V.Yu., et al. The prevalence of chronic heart failure in the European part of the Russian Federation (part 2) – EHPOHA-HSN. Serdechnaya nedostatochnost. 2006;7,3(37):112-5. (In Russ.)
4. Napalkov D.A., Sulimov V.A., Seidov N.M. Chronic heart failure: shift of focus on the initial stages of the disease. Attending physician [Lechashhiĭ vrach]. 2008;4:14–18. (In Russ.)
5. Levy D., Anderson K., Savage D. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factor. The Framingham Heart Study. Ann Intern Med. 1988;108:7–14.
6. Owan T.E., Hodge D.O., Herges R.M. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2006;7:251–259.
7. Bratia R.S., Tu J.V., Lee D.S. Outcome of Heart Fallure with Preserved Ejec- tion Fraction in a Population-Based Study. N Engl J Med. 2006;7:260–269.
8. Yancy C.W., Lopatin M., Stevenson L.W. Clinical presentation, management, and in- hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function. A report from the acute decompensated heart failure national registry (ADHERE) database. Am Coll Cardiol. J. 2006;47:76–84.
9. Shutov A.M., Tarmonova L.Yu. Kidney dysfunction and anemia in elderly patients with diastolic heart failure. Ther. archive [Ter. arhiv]. 2007;12:25–27. (In Russ.)
10. Fonarow G.C.? Stough W.G., Abraham W.T. For the OPTIMIZE-HF investigators and hospitals. Characteristics, treatments and outcomes of patients with preserved systolic function hospitazed for heart failure. Am Coll Cardiol. J. 2007;50:768–777.
11. Triboulloy C. et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J. 2008;29:339–347.
12. Ponikowski P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016 July 14;37(27):2129–2200.
13. McMurray J.J.V. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2012;33:1787–1847.
14. Lyle M.A., and Brozovich F.V. HFpEF, a Disease of the Vasculature: A Closer Look at the Other Half 2018. Mayo Foundation for Medical Education and Research n Mayo Clin Proc. 2018;nn(n):1-10.
15. Reddy Y.N., Borlaug B.A. Heart failure with preserved ejection fraction. Curr Probl Cardiol. 2016;41(4):145-188.
16. Gladden J.D., Linke W.A., Redfield M.M. Heart failure with pre- served ejection fraction. Pflugers Arch. 2014;466(6):1037-1053.
17. Redfield M.M. Heart failure with preserved ejection fraction. N Engl J Med. 2016;375(19):1868-1877.
18. Bakris G.L., Bank A.J., Kass D.A., Neutel J.M., Preston R.A., Oparil S. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. American Journal of Hypertension. 2004;17(12 Pt 2):23S–30S. doi:10.1016/j.amjhyper.2004.08.022. PMID 15607432.
19. Little W.C., Zile M.R., Kitzman D.W., Hundley W.G., O’Brien T.X., Degroof R.C. The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. Journal of Cardiac Failure. 2005;11(3):191–195. PMID 15812746.
20. Ji Y., Wang T., Zhang X., Li L., Li L., Guo Y., Yang B., Wang Y., Zhu T. Astragalosides increase the cardiac diastolic function and regulate the «Calcium sensing receptor-protein kinase C-protein phosphatase 1» pathway in rats with heart failure. Biomed Pharmacother. 2018 Jul;103:838-843. doi: 10.1016/j.biopha.2018.04.111. Epub 2018 Apr 24.
21. Healthcare in Russia 2017. Statistical collection, Rosstat. М., 2017. (In Russ.)
22. Christopher A.P., Sandor J.K. The Role of Left Atrial Function in Dia- stolic Heart Failure. Circ Cardio-vasc Imaging. 2009;2:6–9.
23. The International Network of Agencies for Health Technology Assessment (INAHTA). 2015. [Electronic resource]. Access mode: http://htaglossary.net/health+technology.
24. Federal Law «On Circulation of Medicines» dated 12.04.2010 N 61-FZ (last edition). Consultant Plus. 2019. [Electronic resource]. Access mode: http://www.consultant.ru/document/cons_doc_LA/. (In Russ.)
Review
For citations:
Pavlysh EF, Khirmanov VN, Pavlysh AV. Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects. Meditsinskiy sovet = Medical Council. 2019;(6):14-19. (In Russ.) https://doi.org/10.21518/2079-701X-2019-6-14-19
Views:
1113
Email this article 